Skip to main content

Table 2 Summary of general statistical patient data

From: Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Number of Patients

Histology

 Biphasic

7

 Epithelioid

73

 Sarcomatoid

6

 Unknown

5

Age [Years]

 Minimum

34.57

 Median

64.86

 Mean

64.26

 Maximum

81.76

 Unknown

4

Time to death [month]

 Minimum

0.77

 Median

17.33

 Mean

21.69

 Maximum

81.73

 Unknown

4

Clinical outcome

 Alive

9

 Dead

78

 Unknown

4